Simcere and Stanford Partner on Novel IPF Therapy Research
HONG KONG and STANFORD, Calif., June 12, 2026 Simcere Pharmaceutical Group Limited has entered into a strategic research collaboration...
Generative AI
Advertisement
Novartis Advances First Targeted Therapy for Chronic Inducible Urticaria
BASEL, Switzerland, June 12, 2026 Novartis announced new Phase III data at the European Academy of Allergy and Clinical...
XtalPi Advances AI-Powered Drug Discovery Through $400M GPCR Collaboration
BOSTON and SHENZHEN, China, June 10, 2026 XtalPi, a global leader in AI and robotics-driven drug discovery, has announced...
Pfizer Partners with Chai Discovery to Accelerate AI-Powered Drug Discovery
SAN FRANCISCO, June 4 2026 Chai Discovery has announced a strategic license agreement with Pfizer that will enable the...
Lundbeck and Cradle Harness AI to Accelerate CNS Drug Discovery
VALBY, Denmark and AMSTERDAM, Netherlands, June 3, 2026 Lundbeck and Cradle have announced a strategic partnership aimed at transforming...
Advertisements
Alnylam and Inceptive Forge $2B AI-RNAi Discovery Alliance
CAMBRIDGE, Massachusetts, USA & PALO ALTO, California, USA, June 3, 2026 Alnylam Pharmaceuticals and Inceptive Nucleics have announced a...
Human Longevity and Insilico Launch AI Longevity Platform
SOUTH SAN FRANCISCO, California, May 27, 2026 Human Longevity, Inc. (HLI) has announced the creation of Human Life Foundation...
Incyte Expands AI Drug Discovery With Genesis
WILMINGTON, Del. & SAN MATEO, Calif., May 20, 2026 Incyte and Genesis Molecular AI have announced a significant expansion...
Insilico Medicine Launches Longevity Board for AI Drug Discovery
Cambridge, Massachusetts, USA, April 21, 2026 In a transformative step for AI-driven biotechnology and longevity science, Insilico Medicine has...
Insilico Medicine Advances ISM6200 for Cancer Therapy
HONG KONG | April 10, 2026 Insilico Medicine has announced the nomination of ISM6200, a potential best-in-class selective NR3C1...
Advertisement
